Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Symptomatic Diabetic Neuropathy (SYDNEY 2)

NCT00328601 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

170

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Polyneuropathy

Interventions

DRUG: Thioctic Acid

Sponsor

MEDA Pharma GmbH & Co. KG